Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases. ACCEPTABLE USE POLICY We welcome your comments on our page but we as...See more
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Address:
SUITE 10- 25 CHAPMAN STREET; BLACKBURN NORTH; MELBOURNE, VICTORIA 3130, AU
LOW
spending power
